Spreadsheet Data
Audit the saved peer set and the method inputs behind the blended fair value.
Review the saved peer set across price, scale, operating metrics, and raw valuation multiples.
| Peer | Price | Market Cap | Enterprise Value | Revenue |
|---|
| EBITDA |
|---|
| Net Income |
|---|
| P/E |
|---|
| P/S |
|---|
| EV/EBITDA |
|---|
CI CI Cigna Group FY ended Jan 30, 2026 | $278.65 | $73.63B | $142.17B | $274.90B | $10.87B | $6.29B | 12.56x | 0.27x | 13.07x |
CN CNC CENTENE CORP FY ended Feb 13, 2026 | $64.69 | $31.96B | $48.29B | $194.78B | -$4.73B | -$6.67B | -4.78x | 0.16x | — |
EL ELV Elevance Health, Inc. FY ended Feb 01, 2026 | $397.21 | $86.14B | $101.15B | $199.13B | $8.46B | $5.66B | 15.76x | 0.43x | 10.92x |
HU HUM HUMANA INC FY ended Jan 31, 2026 | $391.32 | $46.98B | $48.43B | $129.66B | $2.76B | $1.19B | 39.77x | 0.36x | 12.36x |
UN UNH UNITEDHEALTH GROUP INC FY ended Feb 20, 2026 | $394.67 | $354.25B | $432.37B | $447.57B | $20.65B | $12.06B | 29.83x | 0.79x | 16.39x |
See which peer averages feed the weighted fair value and which methods are excluded.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVExcluded | Enterprise Multiple | 16.08x | 4/5 | -$7.85B | — | Target fundamentals do not produce a usable positive equity value. |
Price / Sales PSActive | Equity Multiple | 0.40x | 5/5 | $4.72B | $15.73 | Included in the active peer mix. |
Price / Earnings PEExcluded | Equity Multiple | 18.63x | 5/5 | -$8.25B | — | Target fundamentals do not produce a usable positive equity value. |
Open the saved peer table used to audit the fair value view.
| Peer | Price | Market Cap | Enterprise Value | Revenue | EBITDA | Net Income | P/E | P/S | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
CI CI Cigna Group FY ended Jan 30, 2026 | $278.65 | $73.63B | $142.17B | $274.90B | $10.87B | $6.29B | 12.56x | 0.27x | 13.07x |
CN CNC CENTENE CORP FY ended Feb 13, 2026 | $64.69 | $31.96B | $48.29B | $194.78B | -$4.73B | -$6.67B | -4.78x | 0.16x | — |
EL ELV Elevance Health, Inc. FY ended Feb 01, 2026 | $397.21 | $86.14B | $101.15B | $199.13B | $8.46B | $5.66B | 15.76x | 0.43x | 10.92x |
HU HUM HUMANA INC FY ended Jan 31, 2026 | $391.32 | $46.98B | $48.43B | $129.66B | $2.76B | $1.19B | 39.77x | 0.36x | 12.36x |
UN UNH UNITEDHEALTH GROUP INC FY ended Feb 20, 2026 | $394.67 | $354.25B | $432.37B | $447.57B | $20.65B | $12.06B | 29.83x | 0.79x | 16.39x |
Open the peer-average inputs behind the weighted result.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVExcluded | Enterprise Multiple | 16.08x | 4/5 | -$7.85B | — | Target fundamentals do not produce a usable positive equity value. |
Price / Sales PSActive | Equity Multiple | 0.40x | 5/5 | $4.72B | $15.73 | Included in the active peer mix. |
Price / Earnings PEExcluded | Equity Multiple | 18.63x | 5/5 | -$8.25B | — | Target fundamentals do not produce a usable positive equity value. |
